Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2015 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Selected by People's Bank of China for Anhui SME Cross-Border Investment and Trade Cooperation Conference

SAN FRANCISCO, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan...
October 29, 2015 09:58 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Issuance of Australian Patent No. 61/057,713 Covering Eltoprazine Treatment of Parkinson’s Disease and Alzheimer’s Disease

SAN FRANCISCO, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan...
October 26, 2015 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Appoints Curtis Scribner, MD MBA as Sr. Vice President of Regulatory Affairs

SAN FRANCISCO, Oct. 26, 2015 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan...
October 22, 2015 09:15 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Submits Orphan Drug Designation Application to US FDA for Eltoprazine in the Treatment of Levodopa-Induced Dyskinesia

SAN FRANCISCO, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan...
October 19, 2015 08:00 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at BIO Investor Forum 2015

SAN FRANCISCO, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan...
October 14, 2015 10:30 ET | Source: Amarantus BioScience Holdings, Inc.

Past President of the American Burn Association Dr. David Ahrenholz Provides Video Interview on Potential of ESS for Treatment of Severe Burns

SAN FRANCISCO and GENEVA, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in...
October 08, 2015 08:33 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Reports Preliminary 13-Year Longitudinal Follow-Up Human Patient Data for Engineered Skin Substitute Treatment of Congenital Giant Hairy Nevus

- Single ESS Treatment Provided Successful Skin Replacement on Infant Patient, Supporting Natural Skin Growth That Required no Additional Grafts or Reconstructive Surgery - Data Provides...
October 06, 2015 08:30 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Publication of Study on Targeted Delivery of MANF to Brain Areas Associated With Parkinson's Disease

- Renishaw plc’s convection-enhanced delivery device results in accurate targeting and distribution of MANF to Parkinson’s disease-associated brain areas - - Study confirms the potential of...
October 05, 2015 10:47 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Present at the 2015 Aegis Growth Conference

SAN FRANCISCO and GENEVA, Oct. 05, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in...
October 01, 2015 09:25 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus to Focus Near-Term Development Efforts on Engineered Skin Substitute for Indications in Rare Pediatric Diseases

Company is Currently Evaluating Human Clinical Data From Previous Studies Supporting Clinical Development Program Expansion Beyond Treatment of Adult Burns Into Pediatric Burns Published Data...